IP Library Granted Patent US 11,732,280
Granted Patent B2
US 11,732,280 · App. 17/457,608 · Granted Aug 22, 2023

Polyhydroxyalkanoate production methods and materials and microorganisms used in same

Inventor: Markus D. Herrema (Venice, CA)
Assignee: Newlight Technologies, Inc.
C12P7/625
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,732,280
App. No.
17/457,608
Granted
Aug 22, 2023
Kind
B2
Abstract

Embodiments of the invention relate generally to methods to generate microorganisms and/or microorganism cultures that exhibit the ability to produce polyhydroxyalkanoates (PHA) from carbon sources at high efficiencies. In several embodiments, preferential expression of, or preferential growth of microorganisms utilizing certain metabolic pathways, enables the high efficiency PHA production from carbon-containing gases or materials. Several embodiments relate to the microorganism cultures, and/or microorganisms isolated therefrom.

Claims (13)

1. A culture of methanotrophic microorganisms characterized by:

(a) lack of the genetic material encoding soluble methane monooxygenase (sMMO), failure to transcribe DNA encoding sMMO or translate mRNA encoding sMMO, and/or failure to produce a functional sMMO enzyme;

(b) having the genetic material encoding the ethylmalonyl-CoA pathway, transcribing DNA encoding the ethylmalonyl-CoA pathway, and translating mRNA encoding the ethylmalonyl-CoA pathway; and

(c) the capability of producing polyhydroxyalkanoate (PHA) at intracellular PHA concentrations with a ratio of PHA to non-PHA biomass exceeding 3:1 on a dry weight basis.

2. The culture of claim 1 , consisting essentially of microorganisms characterized by:

(a) lack of the genetic material encoding soluble methane monooxygenase (sMMO), failure to transcribe DNA encoding sMMO or translate mRNA encoding sMMO, and/or failure to produce a functional sMMO enzyme;

(b) having the genetic material encoding the ethylmalonyl-CoA pathway, transcribing DNA encoding the ethylmalonyl-CoA pathway, and translating mRNA encoding the ethylmalonyl-CoA pathway; and

(c) the capability of producing polyhydroxyalkanoate (PHA) at intracellular PHA concentrations with a ratio of PHA to non-PHA biomass exceeding 3:1 on a dry weight basis.

3. A composition comprising isolated microorganisms from the culture of claim 1 .

4. The culture of claim 1 , wherein said culture comprises microorganisms from a genus selected from a group consisting of: Methylosinus, Methylocystis, Methylococcus, Methylobacterium , and Pseudomonas.

5. The culture of claim 1 , wherein said methanotrophic microorganisms exhibit particulate methane monooxygenase activity in the presence of copper ion concentrations between 0.001 micromolar and 1000 micromolar.

6. The culture of claim 1 , wherein said methanotrophic microorganisms exhibit ethylmalonyl-CoA pathway activity in the presence of copper concentrations between 0.001 micromolar and 1000 micromolar.

7. The culture of claim 1 , wherein said characteristics of said microorganisms are obtained due to mutation, genetically-engineered mutation, and/or selection-pressure-induced mutation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2022
From: HERREMA, MARKUS D.
To: NEWLIGHT TECHNOLOGIES, INC.
Reel/Frame 060076/0608 →
Continuity (7)
Continuation 16933838 · Jul 20, 2020
Continuation In Part 16577373 · Sep 20, 2019
Continuation 15643905 · Jul 7, 2017
Continuation 14740056 · Jun 15, 2015
Continuation 13802622 · Mar 13, 2013
Provisional Application 61617534 · Mar 29, 2012
Related Publication 20220195468A1 · Jun 23, 2022
Cited By (2)
US 12,312,629 US 12,571,012